Ever since 2006 when Japanese researcher Shinya Yamanaka showed that you could take an adult cell, such as those in your skin, and reprogram it to act like an embryonic stem cell, the scientific world has looked at these induced pluripotent stem (iPS) cells as a potential game changer. They had the ability to convert … Continue reading New study says stem cells derived from older people may have more problems than we thought.
CIRM
Patient Advocates find their voice in a different language
Packed house for stem cell conference in Tokyo - Adrienne Shapiro front row, second from right One of the many wonderful things about travel is that it opens up your eyes and mind to the fact that, while there are many ways in which people around the world differ from each other, there are also … Continue reading Patient Advocates find their voice in a different language
How do you know what patients want if you never even ask them?
Our mission at CIRM is to accelerate stem treatments to patients with unmet medical needs. But what if those needs are not just unmet, they’re also unknown? What happens when those developing treatments never even bother to ask those they are trying to help if this is what they really need, or want? The question … Continue reading How do you know what patients want if you never even ask them?
Patients are the Heroes at the CIRM Alpha Stem Cell Clinics Symposium
UCSD’s Catriona Jamieson and patient advocate Sandra Dillon at the CIRM Alpha Clinic Network Symposium Sometimes, when you take a moment to stand back and look at what you have accomplished, you can surprise yourself at how far you have come, and how much you have done in a short space of time. Take the … Continue reading Patients are the Heroes at the CIRM Alpha Stem Cell Clinics Symposium
Rare disease underdogs come out on top at CIRM Board meeting
It seems like an oxymoron but one in ten Americans has a rare disease. With more than 7,000 known rare diseases it’s easy to see how each one could affect thousands of individuals and still be considered a rare or orphan condition. Only 5% of rare diseases have FDA approved therapies People with rare … Continue reading Rare disease underdogs come out on top at CIRM Board meeting
New stem cell approach targeting deadly blood cancers
Every four minutes someone in the US is diagnosed with a blood cancer. It might be lymphoma or leukemia, myeloma or myelodysplastic syndromes (MDS). While we have made great strides in treating some of these over the years, we still have a long way to go. Need proof? Well, every nine minutes someone in the US … Continue reading New stem cell approach targeting deadly blood cancers
Family ties help drive UCLA’s search for a stem cell treatment for Duchenne muscular dystrophy
April Pyle, Courtney Young and Melissa Spencer: Photo courtesy UCLA Broad Stem Cell Research Center People get into science for all sorts of different reasons. For Courtney Young the reason was easy; she has a cousin with Duchenne muscular dystrophy. Now her work as part of a team at UCLA has led to a new … Continue reading Family ties help drive UCLA’s search for a stem cell treatment for Duchenne muscular dystrophy
Super stem cell exhibit opens in San Diego
The best science museums are like playgrounds. They allow you to wander around, reading, watching and learning and being amazed as you go. It’s not just a feast for the mind; it’s also fun for the hands. You get to interact with and experience science, pushing buttons, pulling levers, watching balls drop and electricity spark. … Continue reading Super stem cell exhibit opens in San Diego
National honor for helping “the blind see”
Those of us fortunate to have good health take so many things for granted, not the least of which is our ability to see. But, according to the World Health Organization, there are 39 million people worldwide who are blind, and another 246 million who are visually impaired. Any therapy, any device, that can help … Continue reading National honor for helping “the blind see”
Board gives stem cell institute marching orders, and a road map
The poet T. S. Eliot once wrote: “If you aren't in over your head, how do you know how tall you are?” Well, everyone at CIRM, California’s stem cell institute, is about to find out how tall we are. Yesterday our governing Board approved a new Strategic Plan. To call it ambitious might be considered … Continue reading Board gives stem cell institute marching orders, and a road map
The Stem Cellar 